Schaub M, Rössler W, Stohler R
Forschungsgruppe Substanzstörungen der Psychiatrischen Universitätsklinik Zürich West.
Praxis (Bern 1994). 2004 Jun 2;93(23):997-1002. doi: 10.1024/0369-8394.93.23.997.
The present review focuses on articles dealing with clinical or epidemiological studies on the association between cannabis use and psychoses. Included are all articles published since 1990 that were located by a Medline or Psyclit data-base research and those earlier articles that are needed for a correct understanding of studies published during the index episode. The three main topics found are 1) is there evidence for a so called cannabis psychosis 2) do cannabis users exhibit a higher risk of developing a psychotic disorder or 3) does its use worsen the course in established schizophrenia spectrum disorders. The review concludes that very high doses of cannabis can induce a brief psychosis but that this condition is extremely rare. Therefore, such a diagnosis should only be made after careful exclusion of other etiologies. The actual evidence regarding the impact of cannabis use on persons vulnerable to psychosis is not conclusive. Cannabis use seems to worsen the course of schizophrenia spectrum disorders. Adolescents run a higher risk from using cannabis than older people. They should be strongly advised not to indulge in such behaviour.
本综述聚焦于探讨大麻使用与精神病之间关联的临床或流行病学研究文章。纳入的文章包括自1990年以来通过Medline或Psyclit数据库检索到的所有文章,以及为正确理解索引期内发表的研究而必需的早期文章。发现的三个主要主题是:1)是否有证据支持所谓的大麻精神病;2)大麻使用者患精神病性障碍的风险是否更高;3)使用大麻是否会使已确诊的精神分裂症谱系障碍的病程恶化。综述得出结论,非常高剂量的大麻可诱发短暂性精神病,但这种情况极为罕见。因此,只有在仔细排除其他病因后才能做出这样的诊断。关于大麻使用对易患精神病者影响的实际证据尚无定论。大麻使用似乎会使精神分裂症谱系障碍的病程恶化。青少年使用大麻的风险比老年人更高。应强烈建议他们不要沉溺于此类行为。